• Latest Posts

EU Gives Lynparza Green Light as First-Line Ovarian Cancer Treatment

Interview 24 Jul 2018

Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”

In Depth 9 Apr 2018

Are PD-1 and PD-L1 Checkpoint Inhibitors As Good As We Thought?

FDA Approves AstraZeneca’s Lung Cancer Treatment after Rejecting Merck and Pfizer’s

The FDA Gives AstraZeneca’s Breast Cancer Drug the Go-Ahead

Merck and Pfizer’s Checkpoint Inhibitor Fails to Treat Gastric Cancer


European Commission Approves Merck’s PD-L1 Inhibitor for Aggressive Skin Cancer

Designer Babies in Europe: German Merck Set to Receive CRISPR Patent

Merck to Pay Ablynx €15M for Getting a Second Nanobody ready for the Clinic

Unexpected Side Effects: Are we Ready for the Rise of Immunotherapies?

Merck Outsources the Development of its Nanobody for Psoriasis

You Can Now Search Worldwide Genomic Data in a Single Platform